# A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

> **NCT00189501** · — · COMPLETED · sponsor: **Amgen** · enrollment: 1000 (—)

## Conditions studied

- Nephrology

## Interventions

- **DRUG:** Sensipar®

## Key facts

- **NCT ID:** NCT00189501
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1000 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189501, "A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00189501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*